| Health / Medical Topics |
PIM Kinase Inhibitor LGH447
An orally available pan-PIM protein kinase inhibitor with potential antineoplastic activity. PIM kinase inhibitor LGH447 binds to and inhibits the activities of PIM-1, -2 and -3 serine/threonine kinases, which may result in the interruption of the G1/S phase cell cycle transition, the expression of the pro-apoptotic Bcl2 protein and tumor cell apoptosis in cells that overexpress PIMs. PIM kinases, downstream effectors of many cytokine and growth factor signaling pathways, play key roles in cell cycle progression and apoptosis inhibition and may be overexpressed in various malignancies. (NCI Thesaurus)
YOU MAY ALSO LIKE
The initial study examining a new method or treatment.
A two-way valve designed to control the pressure in an endotracheal tube cuff as introduced through a pilot balloon.
A hamartoma characterized by localized pilosebaceous apparatus malformation.
A hair-containing cyst or sinus, occurring chiefly in the coccygeal region.
A recently described astrocytic tumor of uncertain relation to pilocytic astrocytoma. It occurs predominantly in infants and young children. It…
Clonal proliferations arising from cutaneous hair follicles composed in part of cells with basaloid cytology that resemble human pilomatrixomas.
